F. H. Hausheer
- Co-authors
- P. SeetharamuluRichard F. LudueñaAsish R. ChaudhuriPatricia M. SchwarzDhanabalan MuraliJeffrey D. SaxeEpie BovenMiranda Verschraagen
- Topics
- Cancer therapeutics and mechanisms (8 papers)Cancer Treatment and Pharmacology (6 papers)Drug Transport and Resistance Mechanisms (4 papers)
- Journals
- Journal of the American Chemical SocietyJournal of Clinical OncologyJournal of Molecular Biology
- Partner nations
- United StatesJapanNetherlands
In The Last Decade
F. H. Hausheer
22 papers receiving 313 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 163
- Oncology 154
- Organic Chemistry 59
- Pathology and Forensic Medicine 58
- Cell Biology 34
Countries citing papers authored by F. H. Hausheer
This map shows the geographic impact of F. H. Hausheer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. H. Hausheer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. H. Hausheer more than expected).
Fields of papers citing papers by F. H. Hausheer
This network shows the impact of papers produced by F. H. Hausheer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. H. Hausheer. The network helps show where F. H. Hausheer may publish in the future.
Co-authorship network of co-authors of F. H. Hausheer
This figure shows the co-authorship network connecting the top 25 collaborators of F. H. Hausheer. A scholar is included among the top collaborators of F. H. Hausheer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. H. Hausheer. F. H. Hausheer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 17 | |
| 6 | 31 | |
| 7 | 26 | |
| 8 | 6 | |
| 9 | 1 | |
| 10 | 13 | |
| 11 | 1 | |
| 12 | 33 | |
| 13 | 7 | |
| 14 | 43 | |
| 15 | Oral and intravenous BNP7787 protects against paclitaxel-mediated neurotoxicity in Wistar rats | 6 |
| 16 | 13 | |
| 17 | Topotecan lactone selectively binds to double- and single-stranded DNA in the absence of topoisomerase I. | 32 |
| 18 | Polyglutamylation of the dihydrofolate reductase inhibitor gamma-methylene-10-deazaaminopterin is not essential for antitumor activity. | 2 |
| 19 | 0 | |
| 20 | 17 |
About F. H. Hausheer
F. H. Hausheer is a scholar working on Oncology, Toxicology and Dermatology, having authored 23 papers that have together received 340 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (8 papers), Cancer Treatment and Pharmacology (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Toxicology (29 citations), Oncology (154 citations) and Pathology and Forensic Medicine (58 citations). F. H. Hausheer has collaborated with scholars based in United States, Japan and Netherlands. Frequent co-authors include P. Seetharamulu, Richard F. Ludueña, Asish R. Chaudhuri, Patricia M. Schwarz, Dhanabalan Murali, Jeffrey D. Saxe, Epie Boven, Miranda Verschraagen, W. J. F. van der Vijgh and Patrick J. Carroll. Their work appears in journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Journal of Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.